Clarius Group, LLC Biogen Inc. Transaction History

Clarius Group, LLC

$1.44 Billion
Q4 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	BUY	$222.59 - $267.94 $13,355 - $16,076	60 Added 5.64%	1,123 $290,000
Q3 2023 Oct 19, 2023	SELL	$253.3 - $285.89 $88,655 - $100,061	-350 Reduced 24.77%	1,063 $273,000
Q2 2023 Aug 09, 2023	BUY	$275.25 - $318.06 $30,828 - $35,622	112 Added 8.61%	1,413 $402,000
Q1 2023 Apr 17, 2023	SELL	$256.56 - $292.34 $25,912 - $29,526	-101 Reduced 7.2%	1,301 $361,000
Q4 2022 Jan 25, 2023	BUY	$252.44 - $306.72 $6,563 - $7,974	26 Added 1.89%	1,402 $388,000
Q3 2022 Oct 24, 2022	BUY	$194.69 - $268.46 $50,230 - $69,262	258 Added 23.08%	1,376 $367,000
Q2 2022 Aug 10, 2022	SELL	$187.54 - $223.02 $35,820 - $42,596	-191 Reduced 14.59%	1,118 $228,000
Q4 2021 Feb 02, 2022	SELL	$223.92 - $287.77 $56,651 - $72,805	-253 Reduced 16.2%	1,309 $314,000
Q3 2021 Oct 18, 2021	BUY	$282.99 - $369.05 $1,414 - $1,845	5 Added 0.32%	1,562 $442,000
Q2 2021 Aug 06, 2021	SELL	$259.0 - $414.71 $5,439 - $8,708	-21 Reduced 1.33%	1,557 $539,000
Q1 2021 Apr 27, 2021	BUY	$242.95 - $284.63 $72,399 - $84,819	298 Added 23.28%	1,578 $441,000
Q4 2020 Jan 15, 2021	SELL	$236.26 - $355.63 $10,631 - $16,003	-45 Reduced 3.4%	1,280 $313,000
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $65,398 - $75,510	-247 Reduced 15.71%	1,325 $376,000
Q2 2020 Jul 08, 2020	BUY	$258.66 - $342.55 $73,200 - $96,941	283 Added 21.96%	1,572 $421,000
Q1 2020 Apr 24, 2020	BUY	$268.85 - $341.04 $10,485 - $13,300	39 Added 3.12%	1,289 $408,000
Q4 2019 Jan 22, 2020	BUY	$220.06 - $304.07 $29,708 - $41,049	135 Added 12.11%	1,250 $366,000
Q3 2019 Oct 23, 2019	BUY	$217.44 - $243.88 $39,791 - $44,630	183 Added 19.64%	1,115 $260,000
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $34,209 - $37,708	-156 Reduced 14.34%	932 $218,000
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $235,780 - $368,788	1,088 New	1,088 $257,000

Others Institutions Holding BIIB

# of Institutions

1,004

Shares Held

129M

Call Options Held

1.12M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account